Skip to content
Multiple Sclerosis News Today logo Newsletter
Newsletter
  • About MS
    Multiple sclerosis overview
    • Types of MS
    • Causes and risk factors
    • Symptoms
    • Diagnosis
    • Living with MS
    Treatments options for MS
    • Approved treatments
    • Experimental treatments
  • Featured Topics
    Newly diagnosed guide
    • Talking to your kids
    • Videos: Embarking on the MS journey
    • Continuing MS treatment
    • MS and employment
    • Next steps after an MS diagnosis
    • MS caregivers guide
    • MS healthcare team
    • Perspectives on MS diagnosis
    • MS treatment explainer
    • Questions to ask your doctor
    • View all
    MS pathways
    • Temperature sensitivity
    • MS and sleep
    • Videos: Worth the talk
    • Managing RRMS
    • Changing MS therapy
    • Mental health and MS
    • MS spasticity stretches
    • MS apps and tools
    • Energy levels and MS
    • MS and eating
    Living strong
    • MS and chronic pain
    • Stress and MS
    • MS and exercise
    • MS safe home tips
    • MS in women
    • Talking to your doctor
    • Recognizing MS symptoms
    • MS and restless leg syndrome
    Resources
    • MS hug
    • MS and heat
    • Cannabis and MS
    • Lesions and MS
    • Myelin's role in MS
    • Epstein-Barr virus and MS
    • Stem cell therapy for MS
    • MS prognosis and life expectancy
    • MS and mental health
    Expert voices
    • Exercise
    • Pain management
    • Cannabis use
    • Diet and nutrition
    • Financial planning
    • Managing fatigue
    • Sleeping well
    • More
  • News
  • Columns
    Authentically Human – Desiree Lama
    Balancing Grit and Grace – Ahna Crum
    Chairborne — Ben Hofmeister
    Delicate Balance – Leigh Anne Nelson
    Rhythms and Routines – Susan Payrovi, MD
    Archived Columns
    • A Life in Letters — Jamie Hughes
    • DISabled to ENabled — Jessie Ace
    • Dive to Fight MS – Mike Parker
    • Fall Down, Get Up Again — John Connor
    • Goldilochs — Stephen De Marzo
    • Patiently Awakened — Teresa Wright-Johnson
    • The MS Wire — Ed Tobias
    • Silver Linings — Jennifer Powell
    In memoriam
    • Through the Looking Glass — Beth Shorthouse-Ullah
  • Forums
  • Video & Podcasts
    Get Tough on Multiple Sclerosis Video Series
    Get Tough on Multiple Sclerosis Podcast
    The Multiple Sclerosis Podcast
    Video: MS caregiving journey
    Video: MS life changes
  • Advocacy partners
  • What can we help you find today?

Multiple sclerosis guide to clinical trials

Last updated Aug. 6, 2025, by Agata Boxe
✅ Fact-checked by Inês Martins, PhD

What’s a clinical trial?
Benefits and risks
Types of MS trials
Where to find information
Asking the right questions
Other considerations

 

Clinical trials play a crucial role in the development, testing, and approval of new therapies for multiple sclerosis (MS). For people living with MS, they can offer a way to try experimental treatments that aren’t yet available to the public while also contributing to research that could help others in the future.

Understanding how clinical trials work — and what participation involves — can help you make an informed choice about whether one might be right for you.

What’s a clinical trial?

A clinical trial is a research study that examines new treatment approaches in people to see if they’re safe and effective before they can be potentially approved by the U.S. Food and Drug Administration (FDA). This process usually follows preclinical studies in animals.

Trials are essential for advancing MS treatments, from disease-modifying therapies (DMTs) to symptom-relief options. Aside from testing new medications, trials can also look at other approaches that may improve MS management and diagnosis.

MS clinical trials come in four different phases:

  • Phase 1 trials examine a treatment’s safety, determine appropriate dose ranges and regimens, and identify potential side effects in a small group of people.
  • Phase 2 trials, which can last from months to years, further assess safety while beginning to evaluate how well the treatment works in a larger group of participants, often by comparing the new therapy with a standard treatment or placebo.
  • Phase 3 trials involve an even larger population, typically ranging from a few hundred to thousands of patients, and compare the new treatment with existing therapies or a placebo to confirm its effectiveness, monitor side effects, and collect data to support regulatory approval.
  • Phase 4 trials are post-marketing studies conducted after FDA approval, which gather data on the therapy’s long-term safety and effectiveness in real-world settings.

In addition to these phases, pilot trials may also be conducted early on to explore the feasibility of a new intervention, refine study design, or gather preliminary safety and efficacy data before launching larger trials.

The benefits and risks of clinical trials

Before participating in an MS trial, it is essential to consider both the advantages and potential risks involved.

The benefits of clinical trials for MS include:

  • getting access to a new treatment that may work for you
  • taking a proactive role in managing your health
  • helping to advance MS research and find new treatments.

Risks of clinical trials and other issues include:

  • experiencing potential side effects
  • facing disappointment if the new treatment doesn’t work for you
  • having to dedicate time to potential extra tests and doctor visits
  • dealing with the possibility of receiving a placebo instead of an active treatment
  • managing potential costs that may not be covered by insurance.

What types of MS trials are available

MS trials can focus on different aspects of the disease, ranging from slowing disease progression to addressing symptoms such as fatigue and spasticity (muscle tightness and spasms). People with MS can participate in several types of trials, which examine medications to manage the disease, as well as lifestyle interventions and novel diagnostic techniques.

Although not all trials will be ongoing at any given time, some examples of MS trials that may be conducted include:

  • DMT trials, which test new medications that aim to slow disease progression or reduce the frequency of relapses
  • symptom management trials, which explore treatments for MS fatigue, walking difficulties, chronic pain, and other MS symptoms
  • lifestyle and rehabilitation trials, which examine the impact of interventions such as exercise programs, specific diets, and physical therapy on certain symptoms and quality of life
  • diagnostic trials, which evaluate new tools or technologies to better detect or monitor MS and its progression
  • biomarker or imaging studies, which collect blood, spinal fluid, or imaging data to identify potential signs of disease activity or track response to treatment.

Trials may focus on specific MS types and may recruit groups of patients based on age, sex, or disease duration. They may also specify that they are for newly diagnosed patients, who have not received any MS treatment, or for those who have failed specific DMTs.

Where to find information about MS clinical trials

You can find out more about clinical trials for MS by consulting your doctor and reviewing relevant resources. Many of them provide listings of ongoing MS studies, including eligibility criteria and locations.

First, ask your MS doctor, who may be aware of specific trials through hospitals, universities, or research networks and will be able to recommend a trial that’s right for you.

Other sources include:

  • clinicaltrials.gov
  • the National MS Society
  • the Multiple Sclerosis Association of America
  • CenterWatch.

Trial opportunities outside the United States include:

  • EU Clinical Trials Register
  • the U.K.’s ISRCTN Registry
  • MS Society UK
  • MS Australia.

Regardless of the research you may do on your own, talking to your MS doctor first is vital. Only they can determine whether you may be a good candidate for a trial, and if so, what type of trial.

They can also assess how your potential participation may affect your symptoms and current treatment plan and help to navigate these and other issues.

Asking the right questions

Asking questions can help you make a decision about potential trial participation. It is important to know exactly what to ask your MS doctor, the research team, and yourself as you are exploring the process.

Questions to ask your doctor:

  • Am I a good candidate for an MS clinical trial?
  • Are you aware of any clinical trials for MS that would be suitable for my disease type and symptoms?
  • Would participating in a clinical trial affect my current treatment plan?
  • What are the potential risks and benefits of the clinical trial you may be recommending?
  • What would the trial involve regarding treatment, travel, and time commitment?

Questions to ask the research team:

  • What kind of treatment will the trial be testing, and why do you think it will work?
  • What are the potential side effects, and will I receive adequate support if I experience them?
  • Does this study involve a placebo or another MS treatment that is already on the market?
  • What are the chances of my receiving a placebo or another MS treatment versus the new treatment being studied?
  • Who will cover the costs of my participation in the trial, and do I need insurance?

Inquiring about potential costs is especially important. While most trials cover the costs of experimental treatment and any related medical care, that may not be the case for every single study.

If you are currently insured, also ask your insurer whether they can pay for your participation in the study and care for any potential side effects.

Finally, personal reflection can help you determine whether a trial might be right for you. Questions to ask yourself include:

  • What do I hope to gain from the trial, and are my expectations realistic?
  • Am I willing to accept the risks, such as potential side effects or a chance of receiving a placebo?
  • How may this trial impact my daily life?
  • Can I manage the time commitment and potential travel and expenses related to the trial?
  • Am I ready to handle the emotional impact if the new treatment doesn’t work for me?

Other considerations

Joining an MS clinical trial can give you access to new therapies that aren’t yet widely available. Still, it is a personal decision that you should consider carefully, with full awareness of the potential risks and benefits.

Trials may not be right for everyone, but they do play a crucial role in advancing MS research and could be helpful in managing the disease.

If you think you may be interested in a trial, talk to your doctor. They can guide you through the process and help you find a study that is appropriate for your MS type, symptoms, and other individual characteristics.


Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Recent Posts

  • MS patients at lower risk for some digestive cancers, study finds
  • Vitamin D has small but significant benefits for MS patients: Study
  • Don’t just assume new neurological symptoms are because of MS


July 18, 2025 News by Lindsey Shapiro, PhD

New global trial testing oral therapy BMS-986368 for MS spasticity

A global clinical trial has been launched to evaluate the oral therapy candidate BMS-986368 for treating spasticity — muscle stiffness and spasms — in people with multiple sclerosis (MS). The Phase…

July 1, 2025 News by Michela Luciano, PhD

MS patient enrollment complete in trial testing anti-inflammatory drug

Two of three groups — one composed of people with progressive forms of multiple sclerosis (MS), and the other comprising healthy volunteers — have been fully enrolled in a Phase 1b clinical trial…

June 20, 2025 News by Andrea Lobo, PhD

Foralumab nasal spray trial starts dosing patients at Weill Cornell

A multicenter Phase 2a clinical trial testing foralumab nasal spray in people with nonactive secondary progressive multiple sclerosis (SPMS) has begun dosing patients at Weill Cornell Medicine Multiple Sclerosis Center in New York. The …

May 15, 2025 News by Margarida Maia, PhD

Ellagic acid supplements found to ease fatigue in MS in small trial

Three months of daily supplements containing ellagic acid — an antioxidant found naturally in many fruits and plants — significantly reduced disability levels and eased fatigue, depression, and anxiety in people with multiple…

April 15, 2025 News by Andrea Lobo, PhD

AAN 2025: CAR T-cell therapy for MS shows safety, efficacy in trials

Kyverna Therapeutics’ CAR T-cell therapy candidate KYV-101 was deemed safe and well tolerated, and showed preliminary signs of efficacy, in people with progressive forms of multiple sclerosis (MS) in clinical testing. That’s…

April 11, 2025 News by Lindsey Shapiro, PhD

AAN 2025: Gains from CNM-Au8 in RRMS linked to nerve cell repair

Clinical improvements in vision and cognition linked to the use of treatment candidate CNM-Au8 were correlated with signs of nerve cell repair and remyelination among people with relapsing-remitting multiple sclerosis (RRMS), according to…

March 28, 2025 News by Andrea Lobo, PhD

Foralumab Phase 2a trial starts dosing patients at Yale MS Center

A multicenter Phase 2a clinical trial testing Tiziana Life Sciences’  foralumab nasal spray in people with nonactive secondary progressive multiple sclerosis (SPMS) has dosed the first patients enrolled at Yale MS Center. The…

January 21, 2025 News by Patricia Inacio, PhD

First clinical trial of remyelination therapy PTD802 cleared in the UK

The U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) has cleared Pheno Therapeutics to initiate a first-in-human Phase 1 clinical trial to test its oral candidate PTD802 in healthy volunteers. The therapy is…

January 9, 2025 News by Lindsey Shapiro, PhD

Immunic ‘on track’ with MS clinical trials testing vidofludimus calcium

Immunic Therapeutics says it remains “on track” in testing its multiple sclerosis treatment candidate vidofludimus calcium in twin Phase 3 clinical trials with people who have relapsing disease — and in the Phase 2…

January 6, 2025 News by Marisa Wexler, MS

Long-term Tecfidera slows MS disability progression in large trial

Treatment with Tecfidera (dimethyl fumarate) significantly reduces relapse rates for people with multiple sclerosis (MS), and most MS patients on the approved therapy remain free from disability progression for several years. That’s…

Envelope icon

Subscribe to our newsletter

Get regular updates to your inbox.

This field is for validation purposes and should be left unchanged.

Bionews, Inc.

3 W Garden St
Suite 700
Pensacola, FL 32502
Website: bionews.com
Email: [email protected]
Phone: 1-800-936-1363

  • About Us
  • Leadership
  • Our Culture
  • Editorial Policy
  • Advertising Policy
  • Corrections Policy
  • Terms of Service
  • Privacy Policy
  • Careers
  • Contact Us
Disclaimer

This site is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Copyright © 2013-2025 All rights reserved.